Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125244392 | 12524439 | 2 | F | 2016 | 20160630 | 20160704 | 20160715 | EXP | NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-117791 | RANBAXY | 69.00 | YR | M | Y | 0.00000 | 20160715 | OT | NO | NO |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125244392 | 12524439 | 1 | PS | TEMOZOLOMIDE. | TEMOZOLOMIDE | 1 | Unknown | 160 MG, QD (BASED ON BODY SURFACE AREA OF 2.1M^2) | Y | U | 201742 | 160 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125244392 | 12524439 | 1 | Glioblastoma multiforme |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125244392 | 12524439 | DE |
125244392 | 12524439 | HO |
125244392 | 12524439 | LT |
125244392 | 12524439 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125244392 | 12524439 | Bone marrow failure | |
125244392 | 12524439 | Death | |
125244392 | 12524439 | Decreased appetite | |
125244392 | 12524439 | Lethargy | |
125244392 | 12524439 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |